Read clinical review Dosing & Monitoring GIP/GLP-1 Dual Agonists Titration & Tapering Algorithms A clinician-level guide to tirzepatide titration schedules, dose-escalation pacing, GI tolerability management, and evidence-based tapering strategies for GIP/GLP-1 dual agonists
GLP mimetics are currently widely used in the treatment of Type 2 diabetes while both physiological and pathophysiological effects on the exocrine pancreas are less clear
Awareness of genetic predispositions to ageing supports personalised recommendations that help sustain optimal health and quality of life
A cautious, informed approach guided by a healthcare professional remains the most appropriate course of action for anyone considering this combination
Novo is banking on the pills first-to-market advantage to revitalize sales in the U.S., where it has lost ground to Lilly
Advantages of metformin include the longstanding research supporting its efficacy and safety, an expected decrease in the glycated hemoglobin (HbA1c) level of 1% to 1.5%, low cost, minimal hypoglycemic risk, and potential reductions in cardiovascular (CV) events due to decreased low-density lipoprotein (LDL) cholesterol